Innovation

Molecular Container for the Reversal of Rocuronium Anesthesia

University of Maryland
posted on 08/18/2010

Researchers at the University of Maryland have discovered a new cucurbit[n]uril-type molecular container that meets the requirements for an optimal rocuronium reversal agent. The molecular container has excellent solubility in water (≥ 100 mM) and binds strongly to rocuronium in water. As such the new molecular container can potentially be used as a reversal agent for rocuronium following surgery. A scalable, efficient, and cost effective synthetic route to this compound has also been developed by these same researchers.

Suggested Uses

- Reversal agent for rocuronium following surgery

Advantages

- Highly water soluble
- Containers can be produced in scalable quantities at minimal cost

Innovation Details
 

Detailed Description

Rocuronium is a neuromuscular blocking agent commonly used as general anesthetic during surgery. It is desirable to be able to reverse the effects of rocuronium following surgery for reduced side effects and quick patient recovery. One method to achieve this reversal is the introduction of a molecular container compound capable of strongly and selectively binding to rocuronium. Through chemical binding the rocuronium is removed from the body and the effects of anesthesia are removed. An effective reversal agent would be highly water soluble to allow for intravenous administration using small volumes of liquid.

Researchers at the University of Maryland have discovered a new cucurbit[n]uril-type molecular container that meets the requirements for an optimal rocuronium reversal agent. The molecular container has excellent solubility in water (≥100 mM) and binds strongly to rocuronium in water. As such the new molecular container can potentially be used as a reversal agent for rocuronium following surgery. A scalable, efficient, and cost effective synthetic route to this compound has also been developed by these same researchers.

File Number: LS-2010-001 

Web site: http://otc.umd.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact the case manager at University of Maryland for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation

Icon_avatar

vpajak

Member since
Aug 2010

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...